|
| 37978284 | The type II RAF inhibitor tovorafenib in relapsed/refractory pediatric low-grade glioma: the phase 2 FIREFLY-1 trial. | Nat Med | 2024 |
| 38039965 | A road map for the treatment of pediatric diffuse midline glioma. | Cancer Cell | 2024 |
| 37978284 | The type II RAF inhibitor tovorafenib in relapsed/refractory pediatric low-grade glioma: the phase 2 FIREFLY-1 trial. | Nat Med | 2024 |
| 38039965 | A road map for the treatment of pediatric diffuse midline glioma. | Cancer Cell | 2024 |
| 36124689 | Response assessment in pediatric craniopharyngioma: recommendations from the Response Assessment in Pediatric Neuro-Oncology (RAPNO) Working Group. | Neuro Oncol | 2023 |
| 36124689 | Response assessment in pediatric craniopharyngioma: recommendations from the Response Assessment in Pediatric Neuro-Oncology (RAPNO) Working Group. | Neuro Oncol | 2023 |
| 37584601 | Clinical Efficacy of ONC201 in H3K27M-Mutant Diffuse Midline Gliomas Is Driven by Disruption of Integrated Metabolic and Epigenetic Pathways. | Cancer Discov | 2023 |
| 37810231 | Sex-related incidence and survival differences in pediatric high-grade glioma subtypes: A population-based cohort study. | iScience | 2023 |
| 36711966 | Automated Tumor Segmentation and Brain Tissue Extraction from Multiparametric MRI of Pediatric Brain Tumors: A Multi-Institutional Study. | medRxiv | 2023 |
| 36649671 | Retrospective dataset and survey analyses identify gaps in data collection for craniopharyngioma and priorities of patients and families affected by the disease. | Neoplasia | 2023 |
| 37318058 | PNOC015: Repeated convection-enhanced delivery of MTX110 (aqueous panobinostat) in children with newly diagnosed diffuse intrinsic pontine glioma. | Neuro Oncol | 2023 |
| 36548930 | Outcomes of Infants and Young Children With Relapsed Medulloblastoma After Initial Craniospinal Irradiation-Sparing Approaches: An International Cohort Study. | J Clin Oncol | 2023 |
| 37244226 | Translational considerations for immunotherapy clinical trials in pediatric neuro-oncology. | Neoplasia | 2023 |
| 36738585 | Indigenous peoples and inclusion in clinical and genomic research: Understanding the history and navigating contemporary engagement. | Neoplasia | 2023 |
| 37051331 | Automated tumor segmentation and brain tissue extraction from multiparametric MRI of pediatric brain tumors: A multi-institutional study. | Neurooncol Adv | 2023 |
| 37492101 | OpenPBTA: The Open Pediatric Brain Tumor Atlas. | Cell Genom | 2023 |
| 36916198 | Doing the Work to Improve Diversity in Pediatric Clinical Trials. | Pediatrics | 2023 |
| 37584601 | Clinical Efficacy of ONC201 in H3K27M-Mutant Diffuse Midline Gliomas Is Driven by Disruption of Integrated Metabolic and Epigenetic Pathways. | Cancer Discov | 2023 |
| 37810231 | Sex-related incidence and survival differences in pediatric high-grade glioma subtypes: A population-based cohort study. | iScience | 2023 |
| 37492101 | OpenPBTA: The Open Pediatric Brain Tumor Atlas. | Cell Genom | 2023 |
| 37318058 | PNOC015: Repeated convection-enhanced delivery of MTX110 (aqueous panobinostat) in children with newly diagnosed diffuse intrinsic pontine glioma. | Neuro Oncol | 2023 |
| 37051331 | Automated tumor segmentation and brain tissue extraction from multiparametric MRI of pediatric brain tumors: A multi-institutional study. | Neurooncol Adv | 2023 |
| 37244226 | Translational considerations for immunotherapy clinical trials in pediatric neuro-oncology. | Neoplasia | 2023 |
| 36548930 | Outcomes of Infants and Young Children With Relapsed Medulloblastoma After Initial Craniospinal Irradiation-Sparing Approaches: An International Cohort Study. | J Clin Oncol | 2023 |
| 36649671 | Retrospective dataset and survey analyses identify gaps in data collection for craniopharyngioma and priorities of patients and families affected by the disease. | Neoplasia | 2023 |
| 36916198 | Doing the Work to Improve Diversity in Pediatric Clinical Trials. | Pediatrics | 2023 |
| 36711966 | Automated Tumor Segmentation and Brain Tissue Extraction from Multiparametric MRI of Pediatric Brain Tumors: A Multi-Institutional Study. | medRxiv | 2023 |
| 36738585 | Indigenous peoples and inclusion in clinical and genomic research: Understanding the history and navigating contemporary engagement. | Neoplasia | 2023 |
| 35137228 | Serial H3K27M cell-free tumor DNA (cf-tDNA) tracking predicts ONC201 treatment response and progression in diffuse midline glioma. | Neuro Oncol | 2022 |
| 35814456 | An Integrated Analysis of Clinical, Genomic, and Imaging Features Reveals Predictors of Neurocognitive Outcomes in a Longitudinal Cohort of Pediatric Cancer Survivors, Enriched with CNS Tumors (Rad ART Pro). | Front Oncol | 2022 |
| 36068285 | Circulating tumor DNA sequencing provides comprehensive mutation profiling for pediatric central nervous system tumors. | NPJ Precis Oncol | 2022 |
| 35615720 | A Survey of Patient-Relevant Outcomes in Pediatric Craniopharyngioma: Focus on Hypothalamic Obesity. | Front Endocrinol (Lausanne) | 2022 |
| 36382108 | Phase I dose escalation and expansion trial of single agent ONC201 in pediatric diffuse midline gliomas following radiotherapy. | Neurooncol Adv | 2022 |
| 35852795 | Upfront Biology-Guided Therapy in Diffuse Intrinsic Pontine Glioma: Therapeutic, Molecular, and Biomarker Outcomes from PNOC003. | Clin Cancer Res | 2022 |
| 35137228 | Serial H3K27M cell-free tumor DNA (cf-tDNA) tracking predicts ONC201 treatment response and progression in diffuse midline glioma. | Neuro Oncol | 2022 |
| 35615720 | A Survey of Patient-Relevant Outcomes in Pediatric Craniopharyngioma: Focus on Hypothalamic Obesity. | Front Endocrinol (Lausanne) | 2022 |
| 35852795 | Upfront Biology-Guided Therapy in Diffuse Intrinsic Pontine Glioma: Therapeutic, Molecular, and Biomarker Outcomes from PNOC003. | Clin Cancer Res | 2022 |
| 35814456 | An Integrated Analysis of Clinical, Genomic, and Imaging Features Reveals Predictors of Neurocognitive Outcomes in a Longitudinal Cohort of Pediatric Cancer Survivors, Enriched with CNS Tumors (Rad ART Pro). | Front Oncol | 2022 |
| 36068285 | Circulating tumor DNA sequencing provides comprehensive mutation profiling for pediatric central nervous system tumors. | NPJ Precis Oncol | 2022 |
| 36382108 | Phase I dose escalation and expansion trial of single agent ONC201 in pediatric diffuse midline gliomas following radiotherapy. | Neurooncol Adv | 2022 |
| 33272950 | Pilot Study of Hyperpolarized <sup>13</sup>C Metabolic Imaging in Pediatric Patients with Diffuse Intrinsic Pontine Glioma and Other CNS Cancers. | AJNR Am J Neuroradiol | 2021 |
| 34277419 | Radiation in Combination With Targeted Agents and Immunotherapies for Pediatric Central Nervous System Tumors - Progress, Opportunities, and Challenges. | Front Oncol | 2021 |
| 34244769 | Understanding the global impact of primary brain tumors: The untapped potential of population-based cancer registries. | Neuro Oncol | 2021 |
| 33272950 | Pilot Study of Hyperpolarized <sup>13</sup>C Metabolic Imaging in Pediatric Patients with Diffuse Intrinsic Pontine Glioma and Other CNS Cancers. | AJNR Am J Neuroradiol | 2021 |
| 34277419 | Radiation in Combination With Targeted Agents and Immunotherapies for Pediatric Central Nervous System Tumors - Progress, Opportunities, and Challenges. | Front Oncol | 2021 |
| 34244769 | Understanding the global impact of primary brain tumors: The untapped potential of population-based cancer registries. | Neuro Oncol | 2021 |
| 31104347 | High-grade neuroepithelial tumor with BCOR exon 15 internal tandem duplication-a comprehensive clinical, radiographic, pathologic, and genomic analysis. | Brain Pathol | 2020 |
| 32257279 | Neuro-Oncology Practice Clinical Debate: targeted therapy vs conventional chemotherapy in pediatric low-grade glioma. | Neurooncol Pract | 2020 |
| 32303840 | Pediatric bithalamic gliomas have a distinct epigenetic signature and frequent EGFR exon 20 insertions resulting in potential sensitivity to targeted kinase inhibition. | Acta Neuropathol | 2020 |
| 32392601 | Neurocognitive Outcomes in Children with Brain Tumors. | Semin Neurol | 2020 |